CEL-SCI Reports June Patient Enrollment in Its Phase 3 Head and Neck Cancer Trial
July 01, 2015 at 09:20 AM EDT
CEL-SCI Corporation (NYSE MKT: CVM) ("CEL SCI" or the "Company") today announced that in June it has enrolled 25 patients in its ongoing ...